Medical devices have received frequent policy support this year. Following the “13th Five-Year Plan†to upgrade domestic Medical Equipment to the national strategic position, the “13th Five-Year Plan for Medical Device Technology Innovation†(hereinafter referred to as “Planningâ€) will also be released this year.
A few days ago, the Social Development Department of the Ministry of Science and Technology organized a symposium on “Planning†for comments in Beijing. The framework and content of the Plan were introduced. According to the overall work arrangement, the "Planning" will be officially released this year after further revision and improvement of the opinions of the soliciting department.
"This year's medical devices have received obvious support from the policy. The growth of domestic medical devices in the future is worth looking forward to." Debon Securities analyst Fu Tao said that whether it is the "13th Five-Year Plan" or the "Made in China" promotion plan, etc. In addition, the innovative research and development and quality upgrade of domestic medical devices have been upgraded to an unprecedented height - the position of national strategy. In the medical reform program of the medical reform pilot province Hunan, the pilot city of Shandong Jinan, and the capital Beijing, the use of domestic equipment is encouraged. In addition, from the latest hospital control fees issued by the National Health and Family Planning Commission, one of the key points of the control measures is to preferentially purchase domestic high-value consumables.
According to the “Completion of Major Economic Indicators of the Pharmaceutical Industry in January-April 2016†issued by the Ministry of Industry and Information Technology on July 12, from January to April this year, the added value of the pharmaceutical industry above designated size increased by 9.6% year-on-year, and the enterprises above the scale of the pharmaceutical industry realized the main business. The income was 867.923 billion yuan, a year-on-year increase of 10.4%, higher than the national industry's overall growth rate of 8.1 percentage points, an increase of 0.89 percentage points over the same period of the previous year. Among the sub-sectors, the fastest growth of main business income is medical equipment and equipment, and Chinese herbal medicines.
“In each sub-sector, the fastest growth in profits is chemical raw materials, medical equipment and equipment. The growth rate of medical equipment and the growth rate of profit are at the forefront.†Jing Ying, an analyst at Pacific Securities, said that he is optimistic about the long-term medical equipment industry. Development trend, it is recommended to pay attention to quality medical equipment companies such as Yuyue Medical, Bohui Innovation, Wanfu Biological, Runda Medical.
In August, the Ministry of Industry and Information Technology announced the “Notice on Printing and Implementing Five Major Project Implementation Guidelines for Manufacturing Innovation Centersâ€, among which high-performance medical devices are one of the 11 key areas in the high-end equipment innovation project among the five major projects. High-performance medical devices include five major categories: digital imaging equipment, clinical testing equipment, advanced therapeutic equipment, implantable devices and materials, and health monitoring equipment.
The guide proposes the goal of high-performance medical devices, that is, by 2020, to cultivate 10 leading companies with annual sales income of more than 1.5 billion yuan and R&D investment intensity of more than 10%, each with annual sales exceeding 300 million yuan. Single-series varieties, the domestic market share of their respective leading products entered the top 5, supporting 10 domestic medical equipment companies to build a number of application demonstration centers nationwide, building 10 collaborative research and innovation centers for production, education and research, and building 10 service technologies. A public service platform for innovation and industrialization.
"At present, the market for high-end medical devices is mainly led by foreign-funded enterprises. The five categories of high-performance medical devices in the "Guide" are aimed at the high-end medical device market." Song Kai, an analyst at Huachuang Securities, believes that the development goals are clearly defined. Relevant policies can be expected, and companies with strong R&D capabilities in this field will be optimistic for a long time, and continue to look at the development prospects of Guanxi Biological as the leading domestic biomaterials under this policy.
Huachuang Securities calculated the revenue and R&D of relevant enterprises during the reporting period. In recent years, the companies with operating income exceeding 1.5 billion include Yuyue Medical, Shangrong Medical, Lepu Medical, Dongfulong, Shandong Pharmaceutical, Xinhua Medical, and Run. 9 medical, Dean diagnosis, Xiqiao science, research and development investment of more than 10% of the state of the state of the instrument, crown bio, Kelly, Chutian technology, Jiu'an medical, Di Rui medical, Wanfu biological, Daan gene, Bohui has 9 innovations, but none of them meet the guidelines.
COVID-19 Coronavirus Rapid Test Kit
Anesthesia Medical Co., Ltd. , https://www.honestymed.com